2008
More on strong inference
DeVita V. More on strong inference. Nature Reviews Clinical Oncology 2008, 5: 239-239. PMID: 18437157, DOI: 10.1038/ncponc1126.Peer-Reviewed Original Research
2005
Should the FDA be the doctor of last resort?
DeVita V. Should the FDA be the doctor of last resort? Nature Reviews Clinical Oncology 2005, 2: 423-423. PMID: 16264991, DOI: 10.1038/ncponc0292.Peer-Reviewed Original Research
1993
Dose Intensity
SURBONE A, DeVITA V. Dose Intensity. Annals Of The New York Academy Of Sciences 1993, 698: 279-288. PMID: 8279768, DOI: 10.1111/j.1749-6632.1993.tb17219.x.Peer-Reviewed Original Research
1991
The influence of information on drug resistance on protocol design The Henry Kaplan Memorial Lecture, International Conference on Mulignant Lymphomas, 6–9 June 1990, Lugano, Switzerland
DeVita V. The influence of information on drug resistance on protocol design The Henry Kaplan Memorial Lecture, International Conference on Mulignant Lymphomas, 6–9 June 1990, Lugano, Switzerland. Annals Of Oncology 1991, 2: 93-106. PMID: 2054322, DOI: 10.1093/oxfordjournals.annonc.a057892.Peer-Reviewed Original Research
1984
Governance of science at the National Cancer Institute: perceptions and opportunities in oncogene research.
Fischinger P, DeVita V. Governance of science at the National Cancer Institute: perceptions and opportunities in oncogene research. Cancer Research 1984, 44: 4693-6. PMID: 6467222.Peer-Reviewed Original Research
1978
Future prospectives in the treatment of breast cancer.
Henney J, DeVita V. Future prospectives in the treatment of breast cancer. Seminars In Oncology 1978, 5: 465-8. PMID: 366758.Peer-Reviewed Original ResearchCombination therapy of the lymphomas.
Lewis B, DeVita V. Combination therapy of the lymphomas. Seminars In Hematology 1978, 15: 431-57. PMID: 366762.Peer-Reviewed Original ResearchThe Evolution of Therapeutic Research in Cancer
DeVita V. The Evolution of Therapeutic Research in Cancer. New England Journal Of Medicine 1978, 298: 907-910. PMID: 634335, DOI: 10.1056/nejm197804202981610.Peer-Reviewed Original Research
1974
The design of clinical trials in the therapy of ovarian carcinoma
Young R, DeVita V. The design of clinical trials in the therapy of ovarian carcinoma. American Journal Of Obstetrics And Gynecology 1974, 120: 1012-1024. PMID: 4432892, DOI: 10.1016/0002-9378(74)90143-4.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaCystadenocarcinomaCystadenomaEndometriosisFemaleHumansOvarian NeoplasmsPrognosisResearch DesignConceptsOvarian carcinomaClinical trialsProspective randomized clinical trialsSurvival of patientsCombined modality approachRandomized clinical trialsPrognostic factorsStandardized stagingModality approachTherapySuch trialsCarcinomaMajor causeTrialsPatientsBase lineSurvivalChemotherapyRadiotherapyStagingWomen